Bellicum Pharmaceuticals, Inc.
BLCM · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Market Cap | $22,196 | $17,141 | $20,333 | $60,433 |
| - Cash | $21,837 | $46,156 | $35,495 | $91,028 |
| + Debt | $0 | $0 | $1,169 | $38,035 |
| Enterprise Value | $359 | -$29,015 | -$13,993 | $7,440 |
| Revenue | $1,500 | $6,200 | $500 | $7,143 |
| % Growth | -75.8% | 1,140% | -93% | – |
| Gross Profit | $1,500 | $6,200 | $500 | $7,143 |
| % Margin | 100% | 100% | 100% | 100% |
| EBITDA | -$26,981 | -$24,349 | $2,391 | -$87,364 |
| % Margin | -1,798.7% | -392.7% | 478.2% | -1,223.1% |
| Net Income | -$24,973 | -$9,578 | -$8,619 | -$126,092 |
| % Margin | -1,664.9% | -154.5% | -1,723.8% | -1,765.3% |
| EPS Diluted | -0.81 | -0.83 | -1.5 | -26.92 |
| % Growth | 2.4% | 44.7% | 94.4% | – |
| Operating Cash Flow | -$25,783 | -$23,106 | -$56,650 | -$77,569 |
| Capital Expenditures | -$21 | -$7 | -$625 | -$522 |
| Free Cash Flow | -$25,804 | -$23,113 | -$57,275 | -$78,091 |